期刊
FUTURE MICROBIOLOGY
卷 17, 期 13, 页码 985-988出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2022-0103
关键词
adaptive immune cells; COVID-19; immune checkpoint molecules; Innate immune cells; PD-1; PD-L1; SARS-CoV-2
类别
资金
- Agence Nationale de la Recherche, France [ANR-20-COVI-0093COVIMUNE, ANR-19-CE17-0021]
- NIH [AI157852, AI147903]
Severe COVID-19 patients show dysregulated expression of checkpoint molecules PD-1 and PD-L1, indicating that these molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.
Tweetable abstract Severe COVID-19 patients display dysregulated expression of checkpoint molecules PD-1 and its ligand PD-L1, suggesting that these checkpoint molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
